Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice

European Journal of Pharmacology

Volumn 492, Issue 2-3, 2004, Pages 183-187

  Ukai, Makoto ^a   Okuda, Ami ^a   Mamiya, Takayoshi ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

(Mouse); 4 DAMP; AF DX116; Muscarinic receptor; Pirenzepine; Prepulse inhibition; Scopolamine; Tropicamide

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC M4 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; OTENZEPAD; PIRENZEPINE; SCOPOLAMINE; TROPICAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX;

ANIMALS; CHOLINERGIC ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MUSCARINIC ANTAGONISTS; PIPERIDINES; PIRENZEPINE; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; SCOPOLAMINE; STARTLE REACTION; TROPICAMIDE;

EID: 2642560198     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.066     Document Type: Article

References (27)

1. Baratti C.M., Opezzo J.W., Kopf S.R. Facilitation of memory storage by the acetylcholine M2 muscarinic receptor antagonist AF-DX 116. Behav. Neural Biol. 60:1993;69-74
2. Billard W., Binch H. III, Crosby G., McQuade R.D. Identification of the primary muscarinic autoreceptor subtype in rat striatum as M2 through a correlation of in vivo microdialysis and in vitro receptor binding data. J. Pharmacol. Exp. Ther. 273:1995;273-279
3. Bolden C., Cusack B., Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 260:1992;576-580
4. Braff D.L., Grillion C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49:1992;206-215
5. Caine S.B., Geyer M.A., Swerdlow N.R. Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacol. Biochem. Behav. 43:1992;1201-1208
6. Eglen R.M., Hegde S.S., Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48:1996;531-565
7. Fendt M., Koch M. Cholinergic modulation of the acoustic startle response in the caudal pontine reticular nucleus of the rat. Eur. J. Pharmacol. 370:1999;101-107
8. Furuya Y., Kagaya T., Ogura H., Nishikawa Y. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice. Eur. J. Pharmacol. 364:1999;133-140
9. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berlin). 156:2001;117-154
10. Haley T.J., McCormick W.G. Pharmacological effects of produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15
11. Jones C.K., Shannon H.E. Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats. Eur. J. Pharmacol. 391:2000;105-112
12. Jones C.K., Shannon H.E. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. J. Pharmacol. Exp. Ther. 294:2000;1017-1023
13. Klamer D., Engel J.A., Svenssow L. The nitric oxide synthase inhibitor, L-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berlin). 156:2001;182-186
14. Lazareno S., Buckley N.J., Roberts F.F. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol. Pharmacol. 38:1990;805-815
15. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biology on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308
16. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berlin). 94:1988;507-514
17. 3H]4-DAMP. Eur. J. Pharmacol. 166:1989;459-466
18. Niittykoski M., Ruotsalainen S., Haapalinna A., Larson J., Sirvio J. Activation of muscarinic M3-like receptors and β-adrenoceptors, but not M2-like muscarinic receptors or α-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro. Neuroscience. 90:1999;95-105
19. Rinken A. Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes. J. Pharmacol. Exp. Ther. 272:1995;8-14
20. Stanhope K.J., Mirza N.R., Bickerdike M.J., Bright J.L., Harrington N.R., Hesselink M.B., Kennett G.A., Lightowler S., Sherdown M.J., Syed R., Upton R.L., Wadsworth G., Weiss S.M., Wyatt A. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J. Pharmacol. Exp. Ther. 299:2001;782-792
21. Swerdlow N.R., Geyer M.A. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol. Biochem. Behav. 44:1993;741-744
22. Swerdlow N.R., Caine S.B., Braff D.L., Geyer M.A. The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J. Psychopharmacol. 6:1992;176-190
23. Taira C.A. Muscarinic receptor subtype involvement in brain cholinergic stimulation by intracerebroventricular neostigmine in sinoaortic denervated rats. Gen. Pharmacol. 31:1998;583-588
24. Ukai M., Okuda A. Endomorphin-1, an endogenous μ-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice. Peptides. 24:2003;741-744
25. Ukai M., Shinkai N., Kameyama T. κ-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse. Eur. J. Pharmacol. 281:1995;173-178
26. Ukai M., Itoh J., Kobayashi T., Shinkai N., Kameyama T. Effects of the κ-opioid dynorphin A(1-13) on learning and memory in mice. Behav. Brain Res. 83:1997;169-172
27. Varty G.B., Walters N., Cohen-Williams M., Carey G.J. Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur. J. Pharmacol. 424:2001;27-36